Real Assets

Real Assets

We build future energy systems and resilient infrastructure, backing emerging opportunities in technology, land and water.

Latest news

News

Over half of UK family offices already invest in natural capital strategies

Latest news

News

Over half of UK family offices already invest in natural capital strategies

Featured insight

Insights

A new chapter for VCTs post-Budget

Skip to main content
News

Foresight invests £7 million into The KSL Clinic

Foresight is pleased to announce a £7 million investment into The KSL Clinic, a leading provider of hair replacement treatments, with clinics in Greater Manchester and Kent.

  • The KSL Clinic is a leading provider of hair replacement treatments, with clinics in Manchester and Kent
  • Foresight has invested £7 million to support the growth and development of the Company
  • KSL plans to expand its geographic presence and bring the wellbeing benefits of its treatments to more people

Click here to read the PDF version. 

Manchester, 5 July, 2023: Foresight Group (“Foresight”), a leading regional private equity and infrastructure investment manager, has announced a £7 million investment into The KSL Clinic (“KSL” or the “Company”).

The Company was founded by Lloyd Hume in 2016 and has two clinics – located in Salford, Greater Manchester, and Maidstone, Kent - delivering FUE hair transplant treatments. The investment, from Foresight’s North West focussed fund and its VCTs, will enable it to increase its team and expand its geographic presence. 

KSL has experienced strong growth in recent years, supported by the opening of its clinic in Salford and the addition of new surgeons. The Company’s success has been founded on the excellent service levels it provides to customers, with continual investment in training and facilities - resulting in significant improvements in the wellbeing of patients.

As part of the investment, Mark Edwards will join as CEO and Mike McGrath as Chair; both possess significant experience of working with rapidly growing SMEs and Mark was previously CEO of MiHealthcare, which delivered 4.1x returns for Foresight funds. Foresight’s investment will also support the Company’s management team with its growth ambitions – providing the capital to continue to invest in facilities, create high-quality, sustainable jobs and to expand its geographic reach.

Mark Edwards, CEO of KSL, said: “Partnering with Foresight marks an exciting phase in KSL's journey. Lloyd and the team at KSL have built a great business and with Foresight on-board we have ambitious plans to increase our clinical reach to deliver excellent outcomes for more patients.”

Hugh Minnock, Investment Director at Foresight, added: “KSL is an exciting business and we saw great potential in what has been built to date, along with the wider market. We are delighted to partner with KSL and are confident that with this injection of growth capital, Mark, Mike and the KSL team will accelerate growth and achieve their business ambitions.”

Foresight continues to be one of the most active investors in smaller companies, having completed more than 90 investments into SMEs in 2022, alongside a number of strong exits. In the same year, Foresight’s Private Equity team announced three new funds, a ventures fund acquisition and expanded its regional office network, opening offices in Dublin and Leeds. So far in 2023, Foresight has invested into nearly 40 SMEs and a number of successful exits, including Datapath (11.7x money), Mowgli (3.5x money) and GovGrant (4.5x money).

Additional information

Notes to editors

Related News & Insights

You have viewed 0 of 0